Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Drops By 56.4%

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a large drop in short interest in February. As of February 15th, there was short interest totalling 1,700 shares, a drop of 56.4% from the January 31st total of 3,900 shares. Based on an average daily trading volume, of 1,600 shares, the days-to-cover ratio is presently 1.1 days.

BioSyent Stock Up 0.7 %

BIOYF stock opened at $7.77 on Friday. The business has a 50 day moving average of $7.75 and a 200-day moving average of $7.89. BioSyent has a 12-month low of $5.93 and a 12-month high of $8.90.

BioSyent Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, March 3rd will be given a dividend of $0.0347 per share. The ex-dividend date is Friday, February 28th. This is a positive change from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.77%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.